ZLAB Zai Lab Limited ADRs

Zai Lab Ltd is a biopharmaceutical company. The company is engaged in discovering or licensing, developing and commercializing proprietary therapeutics in the fields of oncology, autoimmune and infectious diseases. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$128.66  +2.27 (1.80%)
As of 09/17/2021 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  Cayman Islands
IPO date:  09/20/2017
Outstanding shares:  95,408,743
Average volume:  429,022
Market cap:   $11,901,286,602
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    98887Q104
ISIN:        US98887Q1040
Sedol:      BD9GVY0
Valuation   (See tab for details)
PE ratio:   -22.72
PB ratio:   7.16
PS ratio:   112.28
Return on equity:   -31.40%
Net income %:   -495.29%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy